FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167300548> ?p ?o ?g. }

• W2167300548 endingPage "2352" @default.
• W2167300548 startingPage "2344" @default.
• W2167300548 abstract "To determine whether the source of autologous hematopoietic stem cells altered the clinical outcomes of patients undergoing high-dose chemotherapy and hematopoietic stem-cell transplantation (HSCT) for aggressive non-Hodgkin's lymphoma (NHL).Of 105 high-risk, persistent, or relapsed NHL patients slated for an autologous HSCT entered onto this trial, 93 eligible patients were randomized to receive cytokine-naive autologous bone marrow transplantation (ABMT) (n = 46) or mobilized peripheral-blood stem-cell transplantation (PBSCT) (n = 47). All patients received carmustine, etoposide, cytarabine, and cyclophosphamide as the conditioning regimen. PBSCT patients also received identical mobilization with granulocyte colony-stimulating factor (G-CSF) 10 microg/kg/d, and both groups received G-CSF 5 microg/kg/d after the infusion of the stem-cell product until neutrophil engraftment.PBSCT patients had significantly faster engraftment of all cell lineages: median time to absolute neutrophil count > or = 500/microL, 10 days versus 13 days on the ABMT arm; median time to platelet count greater than 20,000/microL untransfused, 11 days versus 15 days on the ABMT arm; and median time to RBC transfusion independence, 8 days versus 16 days on the ABMT arm. The complete response rate was 72% for PBSCT and 54% for ABMT. The death rate before posttransplant day 100 was 2% on the ABMT arm and 6% on PBSCT arm. Event-free survival was 37% for PBSCT and 37% for ABMT. However, overall survival for PBSCT was 61% compared with 43% for ABMT.Patients with aggressive NHL receiving HSCT randomized to PBSCT demonstrated improved neutrophil engraftment and platelet and RBC transfusion independence. The complete response rate and EFS were not statistically different by randomization arm. Patients whose harvests were positive for minimal residual disease by molecular analysis had poorer EFS." @default.
• W2167300548 created "2016-06-24" @default.
• W2167300548 creator A5015247283 @default.
• W2167300548 creator A5015628512 @default.
• W2167300548 creator A5017386283 @default.
• W2167300548 creator A5021978731 @default.
• W2167300548 creator A5022164102 @default.
• W2167300548 creator A5043351209 @default.
• W2167300548 creator A5048544130 @default.
• W2167300548 creator A5051122129 @default.
• W2167300548 creator A5061471602 @default.
• W2167300548 creator A5066299608 @default.
• W2167300548 creator A5071201232 @default.
• W2167300548 creator A5080373697 @default.
• W2167300548 date "2002-05-01" @default.
• W2167300548 modified "2023-10-01" @default.
• W2167300548 title "Autologous Transplantation for Aggressive Non-Hodgkin’s Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease" @default.
• W2167300548 cites W1541496572 @default.
• W2167300548 cites W160332237 @default.
• W2167300548 cites W1722308804 @default.
• W2167300548 cites W1822252547 @default.
• W2167300548 cites W1888347784 @default.
• W2167300548 cites W1901299664 @default.
• W2167300548 cites W1912693401 @default.
• W2167300548 cites W1939946230 @default.
• W2167300548 cites W1997353354 @default.
• W2167300548 cites W2005141687 @default.
• W2167300548 cites W2020751729 @default.
• W2167300548 cites W2046237319 @default.
• W2167300548 cites W2063809730 @default.
• W2167300548 cites W2084630860 @default.
• W2167300548 cites W2121960093 @default.
• W2167300548 cites W2138917119 @default.
• W2167300548 cites W2209640220 @default.
• W2167300548 cites W2263814165 @default.
• W2167300548 cites W2312878488 @default.
• W2167300548 cites W2324339443 @default.
• W2167300548 cites W2328421359 @default.
• W2167300548 cites W2340074707 @default.
• W2167300548 cites W4205736005 @default.
• W2167300548 cites W4251621571 @default.
• W2167300548 cites W72650883 @default.
• W2167300548 doi "https://doi.org/10.1200/jco.2002.09.138" @default.
• W2167300548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11981006" @default.
• W2167300548 hasPublicationYear "2002" @default.
• W2167300548 type Work @default.
• W2167300548 sameAs 2167300548 @default.
• W2167300548 citedByCount "84" @default.
• W2167300548 countsByYear W21673005482012 @default.
• W2167300548 countsByYear W21673005482013 @default.
• W2167300548 countsByYear W21673005482014 @default.
• W2167300548 countsByYear W21673005482015 @default.
• W2167300548 countsByYear W21673005482016 @default.
• W2167300548 countsByYear W21673005482017 @default.
• W2167300548 countsByYear W21673005482018 @default.
• W2167300548 countsByYear W21673005482019 @default.
• W2167300548 countsByYear W21673005482021 @default.
• W2167300548 countsByYear W21673005482022 @default.
• W2167300548 countsByYear W21673005482023 @default.
• W2167300548 crossrefType "journal-article" @default.
• W2167300548 hasAuthorship W2167300548A5015247283 @default.
• W2167300548 hasAuthorship W2167300548A5015628512 @default.
• W2167300548 hasAuthorship W2167300548A5017386283 @default.
• W2167300548 hasAuthorship W2167300548A5021978731 @default.
• W2167300548 hasAuthorship W2167300548A5022164102 @default.
• W2167300548 hasAuthorship W2167300548A5043351209 @default.
• W2167300548 hasAuthorship W2167300548A5048544130 @default.
• W2167300548 hasAuthorship W2167300548A5051122129 @default.
• W2167300548 hasAuthorship W2167300548A5061471602 @default.
• W2167300548 hasAuthorship W2167300548A5066299608 @default.
• W2167300548 hasAuthorship W2167300548A5071201232 @default.
• W2167300548 hasAuthorship W2167300548A5080373697 @default.
• W2167300548 hasConcept C126322002 @default.
• W2167300548 hasConcept C141071460 @default.
• W2167300548 hasConcept C2776694085 @default.
• W2167300548 hasConcept C2776755627 @default.
• W2167300548 hasConcept C2777408962 @default.
• W2167300548 hasConcept C2778041864 @default.
• W2167300548 hasConcept C2778119113 @default.
• W2167300548 hasConcept C2779338263 @default.
• W2167300548 hasConcept C2780147359 @default.
• W2167300548 hasConcept C2911091166 @default.
• W2167300548 hasConcept C71924100 @default.
• W2167300548 hasConceptScore W2167300548C126322002 @default.
• W2167300548 hasConceptScore W2167300548C141071460 @default.
• W2167300548 hasConceptScore W2167300548C2776694085 @default.
• W2167300548 hasConceptScore W2167300548C2776755627 @default.
• W2167300548 hasConceptScore W2167300548C2777408962 @default.
• W2167300548 hasConceptScore W2167300548C2778041864 @default.
• W2167300548 hasConceptScore W2167300548C2778119113 @default.
• W2167300548 hasConceptScore W2167300548C2779338263 @default.
• W2167300548 hasConceptScore W2167300548C2780147359 @default.
• W2167300548 hasConceptScore W2167300548C2911091166 @default.
• W2167300548 hasConceptScore W2167300548C71924100 @default.
• W2167300548 hasIssue "9" @default.
• W2167300548 hasLocation W21673005481 @default.
• W2167300548 hasLocation W21673005482 @default.
• W2167300548 hasOpenAccess W2167300548 @default.

• next